• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
EX1 0.00% 1.1¢

EXOPHARM LIMITED - Charts / Financials

Exopharm Limited is an Australia-based company, which is involved in advancing Genetic... Exopharm Limited is an Australia-based company, which is involved in advancing Genetic Medicines and other exosome-based medicines using exosomes or extracellular vesicles (EVs) as a chassis for improved and non-viral drug delivery. The Company invests in biopharmaceutical drug development. The Company is engaged in exosome technology and holds a portfolio of intellectual property and know-how related to exosomes and the manufacture of exosomes. The Company’s exosome technologies solve needs for the success of exosome medicines, LEAP manufacturing technology, LOAD API loading technologies and EVPS tropism technologies. The Company is making its proprietary technologies available to pharmaceutical and biotechnology companies that want to harness exosome delivery for their own products.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

refresh Created with Sketch. REFRESH
Last update - 15.59pm 03/05/2024 (20 minute delay) ?
Day
Open 0.0¢   Day High 0.0¢   Day Low 0.0¢
Daily Volume 0
Bids   Sellers
Number Price Volume   Number Price Volume
0 0.0¢ 0   0 0.0¢ 0

Directors & Senior Management

Dr. Christopher Baldwin Deputy Chief Executive Officer, Chief Commercial Officer
Mr. David Franks Company Secretary
Mr. Mark Davies Non-Executive Independent Chairman of the Board
Mr. Clarke Barlow Non-Executive Director
Mr. Jason Carroll Non-Executive Director
Mr. Gage Jull Non-Executive Director
Mr. Peter Molloy Non-Executive Director

Data source: Refinitiv

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.